✦ LIBER ✦

Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy

✍ Scribed by Hubertus C.E. Buyck; Paul D. Griffiths; Vincent C. Emery

Book ID: 116631916
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 178 KB
Volume: 49
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2010.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotyping Of Human Cytomegalovirus (HCM

Genotyping Of Human Cytomegalovirus (HCMV) In Allogeneic Hematopoietic Stem Cell Transplant Recipients

✍ D.C. Dieamant; S.H.A. Bonon; M.M. Murakami; S.C.B. Costa; A.C. Vigorito 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Development of human cytomegalovirus (HC

Development of human cytomegalovirus (HCMV) antiviral resistance in lung transplant recipients with long-term antiviral therapy

✍ Nell Lurain 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Genotyping of Human Cytomegalovirus (Hcm

Genotyping of Human Cytomegalovirus (Hcmv) Glycoprotein B (Gb) in Hematopoietic Stem Cell Transplant Recipients With Active HCMV infection: Impact of gB Genotypes on the Patient's Outcome

✍ D.C. Dieamant; S.H.A. Bonon; M.M. Murakami; F.J.P. Aranha; G.O. Duarte; V.C.A. F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Lack of association between the kinetics

Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant

✍ Isabel Muñoz; Antonio Gutiérrez; Concepción Gimeno; Amparo Farga; Juan Alberola; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The kinetics of the gB-specific and neutralizing antibody responses to human cytomegalovirus (HCMV) were analyzed in 26 allogeneic stem-cell transplant recipients who either did (n = 20) or did not (n = 6) develop asymptomatic HCMV active infection during the study period. Antibody response profiles

Human Cytomegalovirus DNA kinetics using

Human Cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under Ganciclovir therapy

✍ Christopher Payan; Nary Veal; Lilen Sarol; Mathieu Villarmé; Chan Ngohou; Paul R 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 677 KB

Clinically-based determination of safe D

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients

✍ Daniele Lilleri; Fausto Baldanti; Marta Gatti; Francesca Rovida; Luca Dossena; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemia‐based preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view